Liminatus Pharma LIMN
NASDAQ LIMN
$3.84 -0.07 (-1.79%)
As of: Sep 30, 2026 · 9:49 AM EDT

Liminatus Pharma (LIMN) Debt Ratio (2024 - 2026)

Updated

Liminatus Pharma's (LIMN) Debt Ratio was 0.42 for Q2 2026, down 43.9% from 0.76 a year earlier and down 18.0% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Debt Ratio (2024 - 2026) Analysis & Trends

For FY2025, Debt Ratio at Liminatus Pharma was 2.81, down 23.8% from FY2024.

  • By year, Debt Ratio came in at 3.69 in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 0.52 (Q1 2026), 2.81 (Q4 2025) and 1.07 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Liminatus Pharma 4.78 Mn 4.78 Mn - 0.42
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.42
Mar 31, 2026 0.52
Dec 31, 2025 2.81
Sep 30, 2025 1.07
Jun 30, 2025 0.76
Dec 31, 2024 3.69
API Access

Liminatus Pharma Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=LIMN&period=max&api_key=YOUR_API_KEY